BillionToOne’s Post

Not long to go until #ESMO24! Really excited to be attending along with our talented team of Inizio experts. We will be at booth 431e, ready to answer all your oncology questions. In the meantime, check out our new blog, where Heidi Bell, Group Growth Director, Inizio Evoke Europe, discusses The invisible epidemic of bias in oncology. #ESMO24 #Oncology #ReimagineHealth #OncologyTreatments

Our CEO Iraj Ali shared his perspective on the complexities of launching an IPO in an unpredictable market in the second instalment of Citeline Commercial’s #ScripAsks annual series, which highlights industry leaders, experts and investors’ expectations for the year ahead.   Read the full article here: https://lnkd.in/eCKp9ZMA #Oncology #Neoantigens #Clonals

$ILMN -0.88% in ho-hum mode after last night news. Illumina Inc. finally gave investors such as Carl Icahn (owner an oddlot but more than his holding in $MCD) their wish and announced that they would spin off early cancer detection company GRAIL, with ILMN holders getting 1 GRAIL share for every 6 shares of ILMN. -The collective yawn has something to do with the move being massively after-the-fact momentum-wise. -$ILMN shares have -79% since Aug. 2021 highs, almost in a straight line.

Another great ASCO! We had a wonderful team at ASCO to evaulate the new data presented. They have been hard at work since we left writing up their insights for our ONCrg Conference reports. Reach out if you want more details on our ASCO coverage. #ASCO24 #competitivestrategy #oncology #competitiveintelligence #pharmaCI

ICYMI: LucidQuest Views >>> How our benchmarking analysis contributed to a Hemato-Oncology company’s sales and pricing strategy for specific agents. #Casestudies #Oncology Comment below! >>> lqventures.com

Discover the #QPS Ultimate Guide to #Oncology! Dive into this comprehensive resource filled with the latest insights on #DrugDevelopment, #ClinicalResearch, and the latest news from the QPS #blog. Find the Guide here https://bit.ly/3VnQpWM, or contact us at info@qps.com

Virtual representations of patients, tumors and biological processes will help to transform #oncology drug discovery. Learn more about what's coming in 2024 from our #EurekaBlog: https://okt.to/lWyCOu

FYI: LucidQuest Views >>> How our benchmarking analysis contributed to a Hemato-Oncology company’s sales and pricing strategy for specific agents. #Casestudies #Oncology Comment below! >>> lqventures.com

I’m excited to share the highlights from #impactxm #ASCO2024 comprehensive audit. To request your personalized ASCO 2024 audit presentation, please fill out the contact form here: https://ow.ly/b8PT50SQqbT. Looking forward to discussing the key takeaways & trends!

The road to healthcare innovation is not an easy one. It requires sacrifice, dedication, and willingness to go #AllIn for patients. Follow the journeys of early-stage companies in our "All-In Innovation" series and get a glimpse into their passion and perseverance. #JNJInnovation #Oncology Read more here: https://lnkd.in/eEgR3QiZ #MyCompany